- Concrete Examples
It wasn’t so very long ago that global companies looked down their nose at Chinese companies for lacking a recognizable brand and internal innovation, but China has moved on from copying successful Western products. This is true in manufacturing, and it’s now true in the biopharma industry, as favorable government policy and cheap funding help Chinese companies emerge and expand. They may soon be encroaching on the global markets of established multinationals. So how might current biopharma companies collaborate with new Chinese companies? The Boston Consulting Group have some ideas.
About the Authors
John Wong, Chun Wu, Wen Xie and Vaidyanathan Srikant are professionals with the Boston Consulting Group. They collaborated from the BCG’s Hong Kong, Beijing and Zurich offices.